NCT05661344View on ClinicalTrials.gov

A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 7, 2023

Primary Completion Date

September 13, 2023

Study Completion Date

September 13, 2023

Conditions
Hepatic Insufficiency
Interventions
DRUG

BI 1015550

BI 1015550

Trial Locations (1)

24105

CRS Clinical Research Services Kiel GmbH, Kiel

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05661344 - A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems | Biotech Hunter | Biotech Hunter